ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

BTAI BioXcel Therapeutics Inc

1.341
-0.069 (-4.89%)
15 Jun 2024 - Closed
Delayed by 15 minutes

BioXcel Therapeutics Financial Summary

The current BTAI market cap is 39.25M. The company's latest EPS is USD -6.1167 and P/E is -0.22.

Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 206k457k341k376k582k
Operating Income -51.2M-52.41M-48.3M-19.88M-24.16M
Net Income -52.8M-53.52M-50.49M-22.26M-26.79M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 000375k1.38M
Operating Income -33.6M-82.3M-106.94M-159.65M-171.78M
Net Income -32.97M-82.17M-106.93M-165.76M-179.05M
Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 180.1M140.1M100.45M73.7M82.32M
Total Liabilities 127.1M134.23M141.06M130.21M154.69M
Total Equity 53.01M5.86M-40.61M-56.51M-72.36M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 36.39M219.94M239.44M205.85M73.7M
Total Liabilities 9.5M13.24M17.77M129.08M130.21M
Total Equity 26.9M206.7M221.67M76.78M-56.51M
Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -52.35M-90.56M-128.14M-155.01M-17.71M
Investing N/A -20k-20k-20k N/A
Financing 24.15M24.4M24.4M26.52M26.63M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -27.28M-66.35M-82.15M-135.34M-155.01M
Investing -870k-316k-445k-139k-20k
Financing 18.01M247.36M102.45M96.24M26.52M
Market Cap 39.25M
Price to Earnings Ratio -0.22
Price to Sales Ratio 28.87
Price to Cash Ratio 0.61
Price to Book Ratio -0.7
Dividend Yield -

Share Statistics

Shares Outstanding 29.27M
Average Volume (1 week) 358.29k
Average Volume (1 Month) 626.23k
52 Week Change -93.46%
52 Week High 22.055
52 Week Low 1.32
Spread (Intraday) 1.7 (55.92%)

Company Info

Company Name BioXcel Therapeutics Inc
Address 251 little falls drive
wilmington, delaware 19808
Website https://www.bioxceltherapeutics.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock